H.R. 6710 · 117th Congress

To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to submit to Congress a report on barriers, including regulatory inefficiencies, to domestic manufacturing of active pharmaceutical ingredients, finished drug products, and devices, and for other purposes.

Stage
In committee
Introduced
2022-02-11
Latest action
2022-02-14 · Referred to the Subcommittee on Health.

Votes

No linked votes are available for this bill.